The abstract is read at the publisher; the summary is JClub's.
Metagenomics can profile AMR resistomes and mobile genetic elements from clinical or environmental samples, but gene detection alone often cannot yield mechanistic resistance phenotypes.
- Why it matters: AMR emerges from ecological and evolutionary processes in polymicrobial communities, yet metagenomic “resistance potential” is frequently over-interpreted without functional validation.
- What they did: The review synthesizes study design and analysis choices—sampling, controls, contamination management, and database/parameter effects—plus advances like long-read context resolution and rapid clinical metagenomic sequencing.
- The result: It proposes an evidence ladder and decision-gated workflow that integrate metagenomics with targeted assays and culture-dependent experiments to support only appropriately strong mechanistic claims.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.